Viewing Study NCT00242320


Ignite Creation Date: 2025-12-25 @ 4:20 AM
Ignite Modification Date: 2026-03-03 @ 2:42 PM
Study NCT ID: NCT00242320
Status: COMPLETED
Last Update Posted: 2016-12-02
First Post: 2005-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COPD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COPD View
None chronic obstructive pulmonary disease View
None Roflumilast View